Supplementary Table 2 from Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study

Read full text Summarise with VIRAT
Authors: Melissa Alsina, Nina Shah, Sundar Jagannath, Jonathan L. Kaufman, David Samuel DiCapua Siegel, Nikhil C. Munshi, Jacalyn M. Rosenblatt, Yi Lin, Andrzej J. Jakubowiak, Benjamin Avi Derman, Aojun Li, Pingping Mao
+9 more Maeva Fincker, Ashish Yeri, Nathan Martin, Timothy Campbell, Olivia C. Finney, Anna Truppel-Hartmann, Fabio Petrocca, Jesús G. Berdeja, Noopur S Raje
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

CAR-T cell therapy research Multiple Myeloma Research and Treatments Immunotherapy and Immune Responses

Publication details

Publication date
2 April 2026
Language
EN